TY - JOUR T1 - Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e9 LP - e9 DO - 10.1136/annrheumdis-2017-212838 VL - 78 IS - 1 AU - Young Ho Lee AU - Gwan Gyu Song Y1 - 2019/01/01 UR - http://ard.bmj.com/content/78/1/e9.abstract N2 - We have read with interest the article by Nakaoka and colleagues1 on the efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis. The authors have presented a randomised controlled trial in which they suggest a preference for tocilizumab over placebo for time to relapse of Takayasu arteritis, without any new safety concerns. We would like to draw attention to a few points in this regard.First, Takayasu arteritis and giant cell arteritis share some similarities in terms of … ER -